作者: Chris Dudley , Paul Harden
DOI: 10.1159/000328070
关键词:
摘要: This clinical practice guideline addresses access to kidney transplantation together with the evaluation, selection and preparation of potential transplant recipient. Guidance on medical management recipient is provided in another module Renal Association guidelines available at www.renal.org. Readers should refer joint British Society for Histocompatibility Immunogenetics/ Transplantation document detection characterisation HLA antibodies renal NHS Blood Transplant/British consent solid organ (www.bts.org. uk/standards-and-guidelines.htm) [1]. In this Chronic Kidney Disease stage 5 (CKD 5) includes pre-dialysis patients eGFR <15ml/min/1.73m as well dialysis i.e. CKD 5, 5Tand 5D. an updated version guidance developed by same lead co-authors published 2007 based a review literature between 2010. Where evidence was from RCTs systematic reviews recommendations were these publications. there lack high-quality studies, best taking account previous evaluation North America [2] European Best Practice (ERBP) [3].